Gene · 4738
Papers3,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FBXO11 amplifies type I interferon signaling to exert antiviral effects by facilitating the assemble of TRAF3-TBK1-IRF3 complex. | J Med Virol | 2023 | 36897010 | PubTator, text mining | PubMed |
| Targeting androgen receptor and the variants by an orally bioavailable Proteolysis Targeting Chimeras compound in castration resistant prostate cancer. | EBioMedicine | 2023 | 36893587 | PubTator, text mining | PubMed |
| NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma. | Cancer Cell Int | 2023 | 36890567 | PubTator, text mining | PubMed |
| Based on network pharmacology and bioinformatics to analyze the mechanism of action of Astragalus membranaceus in the treatment of vitiligo and COVID-19. | Sci Rep | 2023 | 36890149 | PubTator, text mining | PubMed |
| The roles of E3 ubiquitin ligases in cancer progression and targeted therapy. | Clin Transl Med | 2023 | 36881608 | PubTator, text mining | PubMed |
| Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies. | Cancer Chemother Pharmacol | 2023 | 36864346 | PubTator, text mining | PubMed |
| USP35 promotes cell proliferation and chemotherapeutic resistance through stabilizing FUCA1 in colorectal cancer. | Oncogenesis | 2023 | 36864055 | PubTator, text mining | PubMed |
| Cullin 3 and Blood Pressure Regulation: Insights From Familial Hyperkalemic Hypertension. | Hypertension | 2023 | 36861484 | PubTator, text mining | PubMed |
| Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity. | Cancer Res Commun | 2023 | 36860653 | PubTator, text mining | PubMed |
| Automated SSHHPS Analysis Predicts a Potential Host Protein Target Common to Several Neuroinvasive (+)ssRNA Viruses. | Viruses | 2023 | 36851756 | PubTator, text mining | PubMed |
| Interaction of Camptothecin Anticancer Drugs with Ribosomal Proteins L15 and L11: A Molecular Docking Study. | Molecules | 2023 | 36838813 | PubTator, text mining | PubMed |
| Transcriptomic and Bioinformatic Analyses Identifying a Central Mif-Cop9-Nf-kB Signaling Network in Innate Immunity Response of Ciona robusta. | Int J Mol Sci | 2023 | 36835523 | PubTator, text mining | PubMed |
| Neddylation of EphB1 Regulates Its Activity and Associates with Liver Fibrosis. | Int J Mol Sci | 2023 | 36834826 | PubTator, text mining | PubMed |
| Weighted Gene Co-Expression Network Analysis (WGCNA) Discovered Novel Long Non-Coding RNAs for Polycystic Ovary Syndrome. | Biomedicines | 2023 | 36831054 | PubTator, text mining | PubMed |
| Nuclear PTEN's Functions in Suppressing Tumorigenesis: Implications for Rare Cancers. | Biomolecules | 2023 | 36830628 | PubTator, text mining | PubMed |
| Review: A silent concert in developing plants: Dynamic assembly of cullin-RING ubiquitin ligases. | Plant Sci | 2023 | 36822503 | PubTator, text mining | PubMed |
| Editorial: Ubiquitin and ubiquitin-like modifications in viral infection and innate immunity. | Front Immunol | 2023 | 36817466 | PubTator, text mining | PubMed |
| LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials. | Front Pharmacol | 2023 | 36817147 | PubTator, text mining | PubMed |
| Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient. | Front Oncol | 2023 | 36816936 | PubTator, text mining | PubMed |
| E3 ligase autoinhibition by C-degron mimicry maintains C-degron substrate fidelity. | Mol Cell | 2023 | 36805027 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4738/papers?page=20